Hcq
- All
- News
- Videos
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
Over 1 Crore PPEs, 10 Crore Anti-Malarial Drug HCQ Distributed To States Free Of Cost: Government
Over 3.04 crore N95 masks, more than 1.28 crore PPE kits and over 10.83 crore HCQ tablets have been distributed among the states, union territories and central institutions, free of cost by the central government since March 11, said the Union Ministry of Health and Family Welfare on Thursday.
-
Centre Allocates 4.24 Crore Hydroxychloroquine Tablets To States
The Union health ministry made the biggest allocation of hydroxychloroquine (HCQ) tablets since the beginning of the COVID-19 pandemic in India by distributing 4.24 crore medicines to the states and Union Territories.
-
HCQ, Chloroquine Do Not Show Antiviral Effect Against Coronavirus, Studies Reveal
Chloroquine and hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, do not show any notable antiviral effect against infections with the novel coronavirus in macaques or human lung cells, according to two new studies in the journal Nature.
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
-
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Treatment
The United States on Monday withdrew emergency use authorizations for two coronavirus treatments favored by President Donald Trump, citing their lack of efficacy and safety concerns.
-
Health Ministry Okays Anti-Malarial Drug HCQ For Early Course Of COVID-19
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating COVID-19 patients in moderate stage of criticality.
-
India Lifts Export Ban On Trump-Touted COVID-19 Drug Hydroxychloroquine
India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential "game changer" in the fight against the COVID-19 pandemic, a minister said late on Wednesday.
-
Anti-Malarial Drug, PPEs Prevented COVID-19 Among Health Workers: Report
Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
US Sends 2 Million Doses Of Anti-Malaria Drug To Brazil: White House
The United States has delivered two million doses of the antimalarial drug hydroxychloroquine (HCQ) to Brazil to fight COVID-19, the White House said Sunday, though the drug has not yet been proven effective against the coronavirus.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
HCQ Should Be Used For COVID-19, Says Indian Medical Body After WHO Alert
Indian researchers have not found any major side-effects of hydroxychloroquine or HCQ and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday.
-
Centre Expands Hydroxychloroquine As Prophylactic For Healthcare, Other Frontline Workers
After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against COVID-19 infection, the Central government has expanded the use of the medicine as prophylaxis to healthcare and other frontline workers deployed in non-COVID and COVID area.
-
India To Send Nearly 1,000 Tonnes Of Paracetamol Raw Material To Europe
India will supply Europe with about 1,000 tonnes of the active pharmaceutical ingredient (API) for common pain reliever paracetamol, a top exports body said, easing export controls on over-the counter medicines used to cope with COVID-19 symptoms.
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
Over 1 Crore PPEs, 10 Crore Anti-Malarial Drug HCQ Distributed To States Free Of Cost: Government
Over 3.04 crore N95 masks, more than 1.28 crore PPE kits and over 10.83 crore HCQ tablets have been distributed among the states, union territories and central institutions, free of cost by the central government since March 11, said the Union Ministry of Health and Family Welfare on Thursday.
-
Centre Allocates 4.24 Crore Hydroxychloroquine Tablets To States
The Union health ministry made the biggest allocation of hydroxychloroquine (HCQ) tablets since the beginning of the COVID-19 pandemic in India by distributing 4.24 crore medicines to the states and Union Territories.
-
HCQ, Chloroquine Do Not Show Antiviral Effect Against Coronavirus, Studies Reveal
Chloroquine and hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, do not show any notable antiviral effect against infections with the novel coronavirus in macaques or human lung cells, according to two new studies in the journal Nature.
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
-
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Treatment
The United States on Monday withdrew emergency use authorizations for two coronavirus treatments favored by President Donald Trump, citing their lack of efficacy and safety concerns.
-
Health Ministry Okays Anti-Malarial Drug HCQ For Early Course Of COVID-19
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating COVID-19 patients in moderate stage of criticality.
-
India Lifts Export Ban On Trump-Touted COVID-19 Drug Hydroxychloroquine
India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential "game changer" in the fight against the COVID-19 pandemic, a minister said late on Wednesday.
-
Anti-Malarial Drug, PPEs Prevented COVID-19 Among Health Workers: Report
Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
US Sends 2 Million Doses Of Anti-Malaria Drug To Brazil: White House
The United States has delivered two million doses of the antimalarial drug hydroxychloroquine (HCQ) to Brazil to fight COVID-19, the White House said Sunday, though the drug has not yet been proven effective against the coronavirus.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
HCQ Should Be Used For COVID-19, Says Indian Medical Body After WHO Alert
Indian researchers have not found any major side-effects of hydroxychloroquine or HCQ and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday.
-
Centre Expands Hydroxychloroquine As Prophylactic For Healthcare, Other Frontline Workers
After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against COVID-19 infection, the Central government has expanded the use of the medicine as prophylaxis to healthcare and other frontline workers deployed in non-COVID and COVID area.
-
India To Send Nearly 1,000 Tonnes Of Paracetamol Raw Material To Europe
India will supply Europe with about 1,000 tonnes of the active pharmaceutical ingredient (API) for common pain reliever paracetamol, a top exports body said, easing export controls on over-the counter medicines used to cope with COVID-19 symptoms.
